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Cinchonine (C19H22N2O) is a natural compound of Cinchona bark. Although cinchonine’s antiplatelet eﬀect has been reported
in the previous study, antiobesity eﬀect of cinchonine has never been studied. The main objective of this study was to investigate
whether cinchonine reduces high-fat-diet- (HFD-) induced adipogenesis and inﬂammation in the epididymal fat tissues of mice
and to explore the underlying mechanisms involved in these reductions. HFD-fed mice treated with 0.05% dietary cinchonine
for 10 weeks had reduced body weight gain (−38%), visceral fat-pad weights (−26%), and plasma levels of triglyceride, free fatty
acids, total cholesterol, and glucose compared with mice fed with the HFD. Moreover, cinchonine signiﬁcantly reversed HFD-
induced downregulations of WNT10b and galanin-mediated signaling molecules and key adipogenic genes in the epididymal
adipose tissues of mice. Cinchonine also attenuated the HFD-induced upregulation of proinﬂammatory cytokines by inhibiting
toll-like-receptor-2-(TLR2-)andTLR4-mediatedsignalingcascadesintheadiposetissueofmice.Ourﬁndingssuggestthatdietary
cinchonine with its eﬀects on adipogenesis and inﬂammation may have a potential beneﬁt in preventing obesity.
1.Introduction
Obesityisdeﬁnedasaphenotypicmanifestationofabnormal
or excessive fat accumulation that alters health and increases
mortality [1]. In obesity phenotypes, the adipose tissue is
inﬂuenced by diet and genes, as well as by their interactions
[2, 3]. Adipocytes are the main cellular component of adi-
pose tissues [4, 5] which is the largest endocrine organ in
the body which secretes numerous cytokines and adipokines
into the circulation altering body physiology in signiﬁcant
ways [6]. In obese people’s adipocytes, both hyperplasia
and hypertrophy [7] are observed. The WNT family of
autocrine and paracrine growth factors regulates adult tissue
maintenance and remodeling and, consequently, is well
suited to mediate adipose cell communication [8]. The
studies on animals have reported that WNT10b and galanin
play important roles in regulating adipogenesis [8]. WNT
signaling repressed adipogenesis by blocking induction of
peroxisome proliferator-activated receptor γ (PPARγ)a n d
CCAAT/enhancer-binding protein α (C/EBPα)[ 8]. In high-
fat-diet-(HFD-)inducedobesity,theexpressionofWNT10b
is decreased, which further reduces the level of β-catenin
transported to nucleus. β-Catenin serves as a cofactor of
forkhead transcription factor 1 (FOXO 1) and binds directly
to FOXO 1 and enhances FOXO 1 transcriptional activity.
FOXO1 competes with T-cell factor (TCF) for interaction
with β-catenin, thereby inhibiting TCF transcriptional activ-
ity and upregulating adipogenesis [9–12]. The HFD also
upregulates galanin, its receptors, and some molecules in
galanin-mediated signaling pathway such as protein kinase C
δ (PKCδ) and extracellular signal-regulated kinases (ERKs)
that induce the expression of target genes of PPARγ and
C/EBPα [13].
Toll-like receptors (TLRs) are pattern-recognition recep-
tors that detect microbial components and lipopolysaccha-
rides and then activate the immune system, thus providing a
ﬁrst line of host defense against infections [14]. TLR signal-
ing functions through two pathways: a MyD88-dependent
pathway and MyD88-independent pathway, both of which
trigger the production of proinﬂammatory cytokines such
as interleukin 6 (IL-6) and tumor necrosis factor-α (TNFα)
[15]. In obesity these cytokines likely contribute to the2 PPAR Research
low-level systemic inﬂammation that is seen in the metabolic
syndrome-associated chronic pathologies such as insulin
resistance [16–20]. In the HFD model, increased plasma free
fatty acids (FFAs) are sensed by TLR2 or TLR4, which acti-
vates the nuclear factor kappa-light-chain-enhancer of acti-
vated B cells (NF-κB) and in turn induces increased expres-
sion of TNFα, interleukin 1β (IL-1β), and IL-6 [21].
Cinchonine (C19H22N2O) is a natural compound found
in Cinchona bark, which also contains alkaloids like quinine,
quinidine, and cinchonidine. These three agents along with
cinchonine have been eﬀectively used as antimalarial drugs
[22]. The other unrelated pharmacological eﬀects of these
alkaloids include reversal of multidrug resistance in diﬀerent
t y p e so ft u m o r s[ 23]. Cinchonine in this regard has much
lowertoxicityandhigheractivitycomparedtootherquinine-
related compounds [24]. Previous studies have reported that
cinchonine is an inhibitor of human platelet aggregation.
Antiplatelet eﬀects of cinchonine are mediated mainly
through the inhibition of Ca2+ inﬂux and PKC pathways in
platelets [25, 26]. Nonetheless, the protective activity of
cinchonine against obesity has never been reported. In this
study, we investigated the antiobesity eﬀect of cinchonine
and its potential mechanism of action on adipocyte diﬀer-
entiation and inﬂammation using obese C57BL/6N mice
induced by the HFD.
2.MaterialsandMethods
2.1. Animal and Diets. Twenty-four male C57BL/6N mice
(Orient, Gyeonggi-do, Korea) were housed in standard cages
and placed in a room where the temperature was kept at
21 ± 2.0◦C, the relative humidity at 50 ± 5%, and the light at
a 12 h light/dark cycle. All the mice consumed a commercial
diet and tap water for one week prior to their division into
three weight-matched groups (n = 8): the normal diet
(ND) group, the high-fat diet (HFD) group, and the 0.05%
cinchonine-supplemented diet (CID) group. The ND was a
puriﬁed diet based on the AIN-76 rodent diet composition.
The HFD was identical to the ND except that 200g of fat/kg
(170g of lard plus 30g of corn oil) and 1% (w/w) cholesterol
were added. The CID was identical to the HFD, except that it
included 0.05% cinchonine supplementation. The diets were
g i v e ni nt h ef o r mo fp e l l e t sf o rt e nw e e k s .
The mice’s food intake was recorded daily, and their
body weights were monitored every week during the feeding
period. At the end of the experimental period, the animals
were anesthetized with ether, following a 12 h period of
fasting. Blood was drawn from the inferior vena cava into
anethylene-diamine-tetra-acetic-acid-(EDTA-)coatedtube,
and the plasma was obtained by centrifuging the blood
at 2,000 × gf o r1 5 m i na t4 ◦C. Four diﬀerent locations
of visceral fat-pads (epididymal, mesenteric, perirenal, and
retroperitoneal) were removed, rinsed with phosphate-
buﬀered saline, and then weighed. The plasma and visceral
fat-pad samples were stored at −70◦C until analysis. This
study adhered to the Guide for the Care and Use of Lab-
oratory Animals developed by the Institute of Laboratory
Animal Resources of the National Research Council and was
approved by the Institutional Animal Care and Use Commit-
tee at Yonsei University in Seoul, South Korea.
2.2.HistologicalAnalysis. Theepididymalfat-padswereﬁxed
in 10% buﬀered formalin and embedded in paraﬃn, cut at
thicknesses of 5μm, and later stained with hematoxylin and
eosin (H&E), for the histological examination of adipocyte.
Tissue sections were observed with a TDI Digicam camera
and mean adipocyte size was determined using TOMORO
ScopeEye 3.5 (Techsan Community, Seoul, Korea).
2.3.BiochemicalAnalysis. Theplasmaconcentrationsoftotal
cholesterol,HDLcholesterol,triglycerides,glucose,andFFAs
were determined enzymatically using commercial kits (Bio-
clinical System, Gyeonggi-do, Korea). Plasma LDL+VLDL
cholesterol levels were calculated by subtracting the HDL
cholesterol from the total cholesterol.
2.4. Semiquantitative RT-PCR and Quantitative Real-Time
RT-PCR Analyses. Total RNA was isolated from the epididy-
mal adipose tissue of each mouse using the Trizol (Invitro-
gen, Carlsbad, CA, USA) and then analyzed by RT-PCR
(n = 8). Four micrograms of the total RNA was reverse-
transcribed using the Superscript II kit (Invitrogen) accord-
ing to the manufacturer’s instructions. The GenBank acces-
sion numbers of the relevant templates and the forward
(F) and reverse (R) primer sequences are shown in Table 1.
Primers were also designed to amplify a 530-bp cDNA frag-
ment encoding glyceraldehydes 3-phosphate dehydrogenase
(GAPDH) as an internal control. The cDNA served as a
template in a 40μL reaction mixture and was processed
using an initial step at 94◦C for 5min, followed by 30∼33
ampliﬁcation cycles (94◦C for 30s; 55∼60◦C for 45s; 72◦C
for 1min) and a ﬁnal elongation for 10min at 72◦C. Five
m i c r o l i t e r so fe a c hP C Rr e a c t i o nw a sm i x e dw i t h1 μLo f
six-fold concentrated loading buﬀer and then loaded onto
a 2% agarose gel containing ethidium bromide. Transcript
amounts were normalized to GAPDH transcript. Real-
time quantitative polymerase chain reaction analyses were
performed with cDNA on a LightCycler Instrument (Roche
Diagnostics, Basel, Switzerland), using the FastStart DNA
Master SYBR Green I (Roche Diagnostics) according to the
protocol provided by the manufacturer. Transcript amounts
were normalized to GAPDH transcript. PCR products were
separated and visualized as described above and band
intensities were quantiﬁed using Quantity One analysis
software (Bio-Rad Laboratories, CA, USA).
2.5. Western Blot Analysis. The epididymal adipose tissue
samples obtained from each mouse were homogenized in
extraction buﬀer containing 100mM Tris-HCl, pH 7.4,
5mM EDTA, 50mM NaCl, 50mM sodium pyrophosphate,
50mM NaF, 100mM orthovanadate, 1% Triton X-100,
1mM phenylmethanesulfonyl ﬂuoride, 2μg/mL aprotinin,
1μg/mL pepstatin A, and 1μg/mL leupeptin. Homogenates
were centrifuged at 1,300 × gf o r2 0m i na t4 ◦C. The protein
concentration of the homogenates was measured by thePPAR Research 3
Table 1: Primer sequences and PCR conditions.
Gene description Primers Sequences (5  →3) Annealing
temperature(◦C)
PCR
product
(bp)
Peroxisome proliferator-activated
receptor gamma2 (PPARγ2)
F
R
TTCGGAATCAGCTCTGTGGA
CCATTGGGTCAGCTCTTGTG 55 148
CCAAT/enhancer-binding protein,
alpha (C/EBPα)
F
R
AAGGCCAAGAAGTCGGTGGA
CCATAGTGGAAGCCTGATGC 55 189
Adipocyte protein 2 (aP2) F
R
ACATGAAAGTGGGAGTG
AAGTACTCTCTGACCGGATG 55 128
Leptin F
R
CTCCAAGGTTGTCCAGGGTT
AAAACTCCCCACAGAATGGG 55 143
Sterol regulatory element-binding
factor 1 (SREBP1c)
F
R
TTGTGGAGCTCAAAGACCTG
TGCAAGAAGCGGATGTAGTC 55 94
Lipoprotein lipase (LPL) F
R
TGCCGCTTTTTGTTTTACC
TCACAGTTTCTGCTCCCAGC 55 172
Secreted frizzled-related protein 5
(SFRP5)
F
R
CTTGGTGTCCTTGCGCTTTA
CTGATGGCCTCATGGAACAG 61 155
Wingless-type MMTV integration site
family, member 10B (WNT10b)
F
R
TTTTGGCCACTCCTCTTCCT
TCCTTTTCCAACCGAAAACC 61 183
Dickkopf 2 (DKK2) F
R
GCATTTCCTTCAGATTGGCA
TCATTCCCTGTTCTTCAGCG 55 144
Galanin receptor 1 (GalR1) F
R
CCAAGGGGGTATCCCAGTAA
GGCCAAACA CTACCAGCGTA 55 147
Galanin receptor 2 (GalR2) F
R
ATAGTGGTGCTCATGCTGGAA
AGGCTGGATCGAGGGTTCTA 60 134
Protein kinase C δ (PKCδ) F
R
CTGAGCGCTGCAAGAAGAAC
TGGAAACTTTGATCCTGCACTGA 60 146
Cyclin D (Cyc-D) F
R
TGGGAAGTTTTGTTGGGTCA
TCCTTGTCCAGGTAATGCCA 55 144
E2F1 F
R
CCTGGAGCATGTTAAAGAAG
CCTCGAGACCAAAGTGATAG 48.9 102
Toll-like receptor 2 (TLR2) F
R
TCTAAAGTCGATCCGCGACA
TACCCAGCTCGCTCACTACG 56.2 344
Toll-like receptor 4 (TLR4) F
R
ACCTCTGCCTTCACTACAGA
AGGGACTTCTCAACCTTCTC 48.6 223
Myeloid diﬀerentiation primary
response gene 88 (MyD88)
F
R
AAGAAAGTGAGTCTCCCCTC
TCCCATGAAACCTCTAACAC 55 149
Toll-interleukin 1 receptor
domain-containing adaptor protein
(Tirap)
F
R
GTGGCCGCTGGAGCAAAGAC
TTGCCTCTGCCATCCACATA 55 370
TNF receptor-associated factor 6
(TRAF6)
F
R
GCACAAGTGCCCAGTTGACA
AGTGTCGTGCCAAGTGATTC 62.7 479
TIR-domain-containing
adapter-inducing interferon-β (TRIF)
F
R
ATGGATAACCCAGGGCCTT
TTCTGGTCACTGCAGGGGAT 56.5 528
Interferon regulatory factor 5 (IFR5) F
R
AATACCCCACCACCTTTTGA
TTGAGATCCGGGTTTGAGAT 53.1 191
Interferon α (IFNα) F
R
ATGGCTAG(G/A)CTCTGTGCTTTCCT
GGGCTCTCCAGA(T/C)TTCTGCTCTG 60.2 500
T u m o rn e c r o s i sf a c t o ra l p h a( T N F α) F
R
TGTCTCAGCCTCTTCTCATT
AGATGATCTGAGTGTGAGGG 55 156
Intereukin 6 (IL-6) F
R
TTGCCTTCTTGGGACTGATG
CCACGATTTCCCAGAGAACA 55 162
Forkhead box transcription factor O1
(FOXO1)
F
R
TCCCAATGGCACAGTCCTTA
AGCAGTCCAAAGATGCCCTT 55.2 185
Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
F
R
AGAACATCATCCCTGCATCC
TCCACCACCCTGTTGCTGTA 60 3214 PPAR Research
Bradford assay (Bio-Rad, Hercules, CA, USA). The pro-
tein samples were subjected to 8% SDS-PAGE and then
electrophoretically transferred to nitrocellulose membranes
(Amersham, Buckinghamshire, UK). The nitrocellulose
membraneswereincubatedovernightwithprimaryantibod-
ies (diluted 1:1,000) at 4◦C. Antibodies to the following
proteins were purchased from the indicated sources: ERK,
phospho-ERK (Thr 202/Tyr 204), interferon regulatory
factor3(IRF3)andβ-cateninfromSantaCruzBiotechnology
(Santa Cruz, CA, USA), and phospho-IRF3 (Ser 396) and β-
actin from Cell Signaling Technology (Beverly, MA, USA).
After the membranes were incubated with the corresponding
secondary antibody, immunoreactive signals were detected
using a chemiluminescent detection system (Amersham,
Buckinghamshire, UK) and were quantiﬁed using Quantity
One analysis software (Bio-Rad).
2.6. Statistical Analysis. The results are expressed as the
mean ± SEM of eight mice in each group. The RT-PCR data
were presented as average ± SEM of at least three separate
experiments. Statistical signiﬁcance was calculated using
one-way ANOVA, followed by Duncan’s multiple range tests.
All the statistical analyses were performed with SPSS 12.0
software. Diﬀerences were considered statistically signiﬁcant
when P<0.05.
3. Results
3.1. Body and Visceral Fat-Pad Weights. Mice fed the HFD
had signiﬁcantly higher body weights than animals fed the
ND. Furthermore, dietary supplementation of the HFD with
cinchonine at 0.05% (wt/wt) signiﬁcantly reduced both ﬁnal
body weight (−20%, P<0.05) and body weight gain after
10 weeks of feeding (−38%, P<0.05) compared with the
values for HFD mice (Figures 1(a) and 1(b)). There were no
statisticaldiﬀerencesinfoodintakeamongthethreediﬀerent
dietgroups(Figure 1(c)).Thetotalvisceralfatpadweightsof
micefedontheHFD,whichwassigniﬁcantlygreaterthanthe
weights of ND mice (by 38%, P<0.05), were reduced when
the mice were administered cinchonine (by 26%, P<0.05).
The epididymal, perirenal, mesenteric, and retroperitoneal
fat-pad weights of the mice given cinchonine were reduced
by 19%, 44%, 43%, and 14%, respectively, compared to
those of HFD-fed mice (P<0.05) (Figures 1(d) and 1(e)).
Histological analysis of adipocyte H&E staining also showed
smaller adipocytes in CID-fed mice (−17%) than in HFD-
fed mice (Figures 1(f) and 1(g)).
3.2. Plasma Biochemistry. HFD-induced hypercholesterole-
mia was signiﬁcantly improved by dietary supplementa-
tion with cinchonine. Plasma concentrations of total and
LDL+VLDL cholesterol in mice fed on the CID were signif-
icantly decreased by 31% and 41%, respectively, compared
to that in the HFD-fed group (Figures 2(a), 2(b) and 2(c)).
HFD-induced elevation in the plasma triglyceride and glu-
cose concentrations was reversed when mice were fed on
the CID (24% and 27% reduction, respectively, P<0.05).
Dietarysupplementationwithcinchoninetendedtodecrease
plasma FFA levels compared to the levels in HFD control
mice;however,thistrenddidnotreachstatisticalsigniﬁcance
(Figure 2(f)). Hepatic levels of cholesterol and triglyceride in
mice fed the CID were signiﬁcantly decreased by 15% and
16%, respectively, compared to that in the HFD-fed mice.
3.3. Expression of Adipogenesis-Related Genes. We assessed
the impact of the dietary cinchonine on the expression of
several genes related to adipogenesis in the epididymal adi-
pose tissue of mice. We found that, compared to HFD-fed
mice, CID-fed mice had decreased expression of secreted
frizzled-related protein (SFRP) 5 and dickkopf (DKK) 2
and increased expression of WNT10b (Figure 3(a)).
Furthermore, CID-fed mice had decreased mRNA levels of
galanin receptor 1 (GalR1), galanin receptor 2 (GalR2),
PKCδ, cyclin D (Cyc-D), and E2F1 (Figure 3(b)). As shown
in Figure 3(c), the mRNA levels of PPARγ2, C/EBPα,
sterol regulatory element-binding protein-1 (SREBP1),
and FOXO1 were signiﬁcantly downregulated in CID mice
compared with those in HFD-fed mice (Figure 3(c)). Similar
results were observed for the mRNA levels of key adipogenic
target genes; expression of leptin, activating protein 2 (aP2)
and lipoprotein lipase (LPL) were down-regulated in CID
group compared to HFD group. To investigate more subtle
diﬀerences between groups, we assessed the expression of
Wnt10b, GalR1, and GalR2, using a quantitative real-time
RT-PCR. In accordance with results obtained by a semiquan-
titative RT-PCR, we found that, compared to HFD-fed mice,
CID-fed mice had increased expression of WNT10b and
decreased expression of GalR1 and GalR2 (Figure 3(d)).
Moreover, Western blot analysis of proteins conﬁrmed that
ERK phosphorylation (Thr202/Tyr204) in CID mice was sig-
niﬁcantly lower while β-catenin level was signiﬁcantly
increased in CID mice compared with that in HFD mice.
3.4. Expression of Inﬂammation-Related Genes. We examined
whether cinchonine can attenuate HFD-induced activation
of TLR-mediated proinﬂammatory signaling in the epididy-
mal adipose tissue of mice. RT-PCR analysis conﬁrmed the
elevated expression of TLR2, TLR4, myeloid diﬀerentiation
primary response gene 88 (MyD88), toll-interleukin 1
receptor domain-containing adaptor protein (Tirap), TNF
receptor-associated factor 6 (TRAF6), and TIR-domain-
containing adapter-inducing interferon-β (TRIF) in HFD-
fed mice (Figure 4(a)). As shown in Figure 4(a), the mRNA
levels of pro-inﬂammatory transcription factors (IRF5) and
target cytokines genes (TNFα, interferon α (IFNα), and IL-
6) were upregulated in HFD group compared to those in ND
group. Our data indicate that cinchonine supplementation
successfully abolished HFD-induced upregulation in the
expression of inﬂammation-related genes. In CID group,
the expression of TLR2, TLR4, Tirap, TRAF6, IRF5, TNFα,
and IFNα was approximately 1.5-fold lower and MyD88 and
TRIF expression was 2-fold lower than that of HFD group.
The protein levels of IRF3 and phospho-IRF3 in the epididy-
mal tissue of mice were determined by Western blot analysis,
and the results showed 29% higher IRF3 phosphorylation in
HFD mice when compared to that in CID mice.PPAR Research 5
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Figure 1: Eﬀect of dietary cinchonine on body weight and fat-pad weights. Mice were fed on ND, HFD, or CID. (a) Changes in body weight
gain and (b) ﬁnal body weight after 10 weeks. (c) Food intake and (d), (e) fat-pad weights. (f) Representative photographs of adipocytes in
the epididymal tissue of mice, 100x magniﬁcation. (g) Quantitative measurements of adipocyte size (the average cross-sectional area of each
adipocyte, um2/cell) in mice fed the ND, HFD, or CID.
4. Discussion
Despite the growing obese population worldwide, pharma-
cotherapy for obesity is limited. In 2010, FDA withdrew
sibutramine from the market due to its association with
increased cardiovascular events and strokes, making orlistat
the one and only drug for obesity. However, new concerns
of potential liver toxicity with orlistat have recently been
raised, further reducing the armamentarium for the combat
of obesity [27]. Therefore, taking into account the limited
eﬃcacy and uncertain safety of the available drugs, an
emphasis should be placed on developing pharmacologic
agents with novel mechanisms for decreasing adipogenesis
and inﬂammation to enhance eﬃcacy and improve safety.
In acute toxicity study, maximal tolerated i.p. dose of
cinchonine was 200mg/kg body in mice [28]. Cinchonine is
structurally similar to quinine which is one of the major
alkaloids isolated from the Cinchona bark. Previous study
showed that, in pentylenetetrazole seizure model, quinine
(60mg/kg BW, i.p.) signiﬁcantly inhibited both induction6 PPAR Research
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β-catenin was normalized to total β-actin level. Bars represent the mean ± SEM, n = 8, P<0.05. Diﬀerent letters are statistically diﬀerent.8 PPAR Research
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Figure 4: Eﬀect of dietary cinchonine on the expression of genes involved in inﬂammation. Mice were fed on the ND, HFD, or CID. (a)
RT-PCR analyses of TLRs-mediated proinﬂammatory cytokine genes. The data shown are the relative density normalized to GAPDH. (b)
Protein levels of phosphorylation of IRF3 (p-IRF3) and total IRF3 in the epididymal adipose tissue of mice analyzed by Western blot. p-IRF3
was normalized to total IRF3 protein level. Bars represent the mean ± SEM, n = 8, P<0.05. Diﬀerent letters are statistically diﬀerent.
and duration of seizure [29]. Based on the results of previous
studies, 0.05% (equivalent to 50mg/kg body weight) cincho-
nine supplementation was used in the present study.
Untilnow,therewerenostudiesoncinchonine’santiobe-
sity eﬀect. Our study showed that cinchonine could be a
potential agent that can solve the concerns related to obesity.
Cinchonine demonstrated more dramatic eﬀect than other
phytochemicals that have been known to exert anti-obesity
eﬀects; 0.05% cinchonine showed higher rate of reductions
compared to EGCG and curcumin in ﬁnal body weight even
though the supplemented dose was higher than or same as
thatofcinchonine[30,31].Itwasreportedthat0.32%EGCG
supplemented group showed 9.4% decrease in ﬁnal body
weight compared to HFD fed mice [32]. 0.05% curcumin
supplementation is also known to lower the body weight
by 11% in the same model [31]. Along with cinchonine’s
eﬀect on body weight reduction, cinchonine decreases the
plasma level of lipid in mice fed on the HFD. Cinchonine
eﬀectively ameliorated hyperlipidemia and hyperglycemia
induced by the HFD; cholesterol, LDL+VLDL cholesterol,
HDL cholesterol, TG, and the plasma glucose levels were
reduced in CID group compared to HFD group. Cinchonine
treatment blunted the HFD-mediated hyperlipidemia and
hyperglycemia that are early symptoms of the metabolic
syndrome and associated disorders.
PPARγ, a member of the nuclear receptor subfamily
of transcription factors, is involved in the expression of
target genes implicated in adipocyte diﬀerentiation [32].
Even though WNT10b and galanin signal through diﬀerent
pathways, they regulate adipogenesis by eventually altering
the expression of PPARγ2 and adipogenic regulators. WNT,
a family of secreted glycoproteins, blocks the induction of
PPARγ2 and C/EBPα which further repress the adipogenesis
through inhibiting the subsequent nuclear translocation of
β-catenin [8]. Galanin, a neuropeptide with 29-30 amino
acids, binds to GalR1 and GalR2 resulting in the activation
of PKCδ.S u b s e q u e n ta c t i v a t i o no fP K C δ can induce the
activation of protein tyrosine kinases that could lead to
ERK activation [33] which is necessary for expression of the
crucial adipogenic regulators and PPARγ.
The HFD has the capacity to modulate both WNT10b
and galanin signaling pathways in adipogenesis (Figure 5)
[34]. Our results demonstrated the decreased expression of
WNT10b and β-catenin, and the increased expression of
galanin, its receptors and down-stream molecules including
PPARγ2 in HFD-fed mice. In the present study, cinchoninePPAR Research 9
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Figure 5: Schematic of the WNT10b and galanin-mediated signaling pathways linked to adipogenesis. In HFD model, increased SFRP5 and
DKK2 inhibit WNT10b to combine with LRP and frizzed receptor. Decreased WNT10b signal transduction increases the phosphorylation
of β-catenin thus reducing the amount of β-catenin transported to nucleus. In HFD model, decreased amount of β-catenin in nucleus
cannot inhibit the activity of PPARγ resulting in the stimulation of adipogenesis. The HFD also increases gene expression in the galanin-
mediated signaling pathway. More galanin binds to its receptors, resulting in increased phosphorylation of ERK, which further induces
Cyc-D. Increased Cyc-D promotes more E2F1 to bind to DP that stimulates the expression of PPARγ2, C/EBPα, and its target genes.
supplementation signiﬁcantly reversed the HFD-induced
elevationsofadipogenicgenesinvolvedinboththeWNTand
galanin-mediated signaling pathways. By markedly upregu-
latingtheexpressionofWNT10banddownregulatingGalRs,
cinchonine consequently reduced the expression of PPARγ2
and its target genes (C/EBPα, leptin, aP2, and LPL). Besides
regulating the WNT and galanin-mediated signaling path-
way, cinchonine might further repress the activation of
PPARγ by reducing the plasma FFA level which is known
as an exogenous ligand for PPARγ. Cinchonine’s eﬀect on
the reduction of visceral fat-pad weights is presumed to be
through altering the WNT and galanin-mediated signaling
pathways, and also through lowering plasma FFA level. Fur-
thermore, in several reports by other investigators, nutrient
excess activates biochemical pathways that initiate cellular
responses designed to limit the oxidation of excess energy
and favor weight gain. Simultaneously, the activation of the
same pathways either directly or indirectly induces the dissi-
pation of excess energy via thermogenesis [35]. Accordingly,
further studies are required to evaluate the possible roles
of cinchonine in fatty acid oxidation and thermogenesis
pathways.
FFA is also an endogenous ligand for TLR2 and TLR4
which play important roles in the pathogenesis of nonin-
fectious, inﬂammatory diseases of host deregulation such as
obesity [36–38]. Mice fed on the HFD have elevated level of
FFAs,furtherinducingtheexpressionsofTLR2andTLR4.Of
two diﬀerent inﬂammatory signaling pathways, TLR4 uses
both MyD88-dependent and MyD88-independent pathways,
whereas TLR2 signals only through a MyD88-dependent
pathway [22]. The increased interaction and recruitment of
adaptor molecules such as MyD88, Tirap, TRIF, and TRAM
with TLRs in HFD model trigger the induction of TRAF6 in
the MyD88-dependent pathway [15]. Then, TRAF6 activates
IRF5 leading to its nuclear translocation and cooperation
with NF-κB[ 15]. In the MyD88-independent pathway,
elevated TRIF promotes the phosphorylation of IRF3 [15].
Both IRF5 and IRF3 stimulate the expression of target
genes such as IL-6, TNFα,a n dI F N α, which act on the TNF
receptor in hypertrophied adipocytes, thereby inducing pro-
inﬂammatory cytokine production via NF-κB-dependent
and -independent mechanisms [39]. Dietary cinchonine
successfully reduced the mRNA levels of TLR2, TLR4,
downstream molecules (MyD88, Tirap, TRIF, TRAF6, IRF5,
and IRF3), and pro-inﬂammatory cytokines (TNFα and
IFNα) in the epididymal adipose tissue of mice fed on the
HFD. In the present study, the plasma concentration of
FFA decreased by cinchonine could also be a factor in the
reduction of obesity-induced inﬂammation. Accordingly,
we presume that cinchonine contributes to lower adipose10 PPAR Research
inﬂammation in the diet-induced obese model by down-
regulatingtheTLR-mediatedsignalingpathwayandlowering
plasma FFA level in mice maintained on the HFD.
In conclusion, our results indicate that cinchonine has
a dramatic suppressive eﬀect on adipogenesis through the
down-regulation of WNT and galanin-mediated adipogen-
esis signaling cascades, and it also attenuates inﬂammation
by repressing TLR2- and TLR4-mediated pro-inﬂammatory
signaling pathways in the adipose tissue of mice fed on the
HFD. In the current study, we demonstrated that cinchonine
is a useful dietary phytochemical for the prevention of not
only obesity, but also adipose inﬂammation.
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